| Title : Disease-modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: A Comparative study with donepezil - Vasilopoulou_2021_Br.J.Pharmacol__ |
| Author(s) : Vasilopoulou F , Rodriguez-Arevalo S , Bagan A , Escolano C , Grinan-Ferre C , Pallas M |
| Ref : British Journal of Pharmacology , : , 2021 |
| Abstract : Vasilopoulou_2021_Br.J.Pharmacol__ |
| ESTHER : Vasilopoulou_2021_Br.J.Pharmacol__ |
| PubMedSearch : Vasilopoulou_2021_Br.J.Pharmacol__ |
| PubMedID: 33817786 |
Vasilopoulou F, Rodriguez-Arevalo S, Bagan A, Escolano C, Grinan-Ferre C, Pallas M (2021)
Disease-modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: A Comparative study with donepezil
British Journal of Pharmacology
:
Vasilopoulou F, Rodriguez-Arevalo S, Bagan A, Escolano C, Grinan-Ferre C, Pallas M (2021)
British Journal of Pharmacology
: